Neuro Pathways: A Cleveland Clinic Podcast for Medical Professionals

Ignacio Mata, PhD, discusses ongoing research that seeks to elucidate the role of women-specific health factors in the severity and progression of Parkinson's disease. This activity is approved for 

Le Hua, MD, discusses the management of older adults with multiple sclerosis and why current treatment paradigms may need to evolve. This activity is approved for 

Gregory Hawryluk, MD, PhD, discusses current knowledge about autoimmunity following brain injuries and what ongoing investigations are hoping to discover. This activity is approved for 

Ignacio Mata, PhD, discusses the Latin American Research consortium on the GEnetics of Parkinson's Disease, which aims to uncover the genetic risk factors that play a role in the development of Parkinson's disease in Latinos. This activity is approved for 

Michael Steinmetz, MD, discusses the evolving field of endoscopic spine surgery and how to integrate this approach into today's practice. This activity is approved for 

Taylor Rush, PhD, reviews the behavioral health challenges facing patients with Parkinson's disease and discusses how to manage these challenges in an interdisciplinary setting. This activity is approved for 

Gregory Hawryluk, MD, PhD, reviews the guidelines for managing patients with severe traumatic brain injury. This activity is approved for 

Amre Nouh, MD, MBA, FAHA, discusses best practices for evaluating and managing patients who present in-hospital with a stroke.

Mark Malkin, MD, discusses the unique challenges and opportunities for brain and spine tumor clinical trials.

Brian Barnett, MD, reviews the current state of psychedelics research and what could be next for the field.

Carrie Hersh, DO, discusses how observational studies using real-world data are allowing for direct comparison of disease-modifying therapies in larger patient populations, answering clinical questions with broad applicability.

Mina Lobbous, MD, MSPH, discusses the long-term management needs of patients who progress into adulthood with NF1.

Nancy Foldvary-Schaefer, DO, MS, discusses differential diagnosis of sleep disorders in adults.

Joshua Johnson, PT, DPT, PhD, discusses the effectiveness of a high-intensity home-based rehabilitation model for patients following a stroke.

Robyn Busch, PhD, discusses prediction models that can assist in identifying patients with epilepsy who may be at increased risk for complications following temporal lobe resection.

Amy Kunchok, MD, delves into a practical approach to the diagnosis and management of autoimmune encephalitis.

Desimir Mijatovic, MD, discusses adjunct therapies for the treatment of headaches in pediatric and adult patients.

Andrew Russman, DO, discusses the management and treatment of moyamoya disease in patients with large artery intracranial occlusive disease.

Joseph Austerman, DO, discusses how psychiatric care is evolving to better meet the needs of the adolescent patient population.

James Leverenz, MD, discusses Cleveland Clinic's postmortem brain autopsy program and how the program's findings contribute to our understanding of Alzheimer's disease mechanisms and influence clinical care.

Charles Bernick, MD, MPH, discusses a decade's worth of data on the cumulative effects of repetitive concussive and subconcussive impacts to the brain in professional athletes.

Sara Davin, PsyD, MPH, outlines the team approach used to provide behavioral pain management to patients undergoing spine surgery, which is translating into better outcomes.

Jessica Caldwell, PhD, ABPP/CN, Director of the Women's Alzheimer's Movement Prevention Center, discusses prevalence, presentation and prevention of Alzheimer's disease in the female population.

Neurosurgeon, Nina Moore, MD, discusses the evolving medical, interventional and surgical landscape for treating AVMs.

Doksu Moon, MD, discusses the evolving use of 7T MRI, fMRI, diffusion tensor imaging, perfusion imaging and focused ultrasound, in the diagnosis and management of neurological conditions.

Vineet Punia, MD, MS discusses the presentation, diagnosis and short and long-term management of acute symptomatic seizures.

Francois Bethoux, MD, discusses the comprehensive needs of adults with cerebral palsy, and the call for more physicians to champion patient-centered medical homes for these individuals.

Rob Wilson, DO, addresses the often challenging diagnosis and management of postural orthostatic tachycardia syndrome (POTS), as well as the mounting evidence that that number of individuals afflicted with POTS has grown, and continues to grow, with the arrival of SARS-CoV-2.

Clinicians and researchers are eager to investigate additional applications of focused ultrasound beyond current, approved use for tremor and tremor-dominant Parkinson's disease. In this episode we're discussing current and novel uses of focused ultrasound for neurological disorders.

A first-of-its-kind study from Cleveland Clinic showed that the presenting clinical phenotype of Alzheimer's disease or Lewy body dementia — along with neuropathology and a patient's age and sex — predicted the likelihood of subsequently developing specific behavioral and psychological symptoms. In this episode, Jagan Pillai, MD, PhD discusses these findings and what they mean for the future of dementia practice and research.

Jay Alberts, PhD & Susan Linder, DPT discuss a decades worth of research on the use of forced exercise to improve symptoms of neurodegenerative diseases and recovery post acute neuro events, like stroke.

Gabor Toth, MD, surveys the current landscape of stroke treatment and discusses new developments on the horizon. Receive CME credit for listening to this podcast by visiting clevelandclinic.org/neuropodcast and selecting this episode.

Pavan Tankha, DO, discusses intravenous ketamine and its use in functional restoration for patients with chronic pain. Receive CME credit for listening to this podcast by visiting clevelandclinic.org/neuropodcast and selecting this episode.

William Bingaman, MD, discusses the current state of epilepsy surgery and its value in care of individuals who have failed anti-seizure medications. Receive CME credit for listening to this podcast by visiting clevelandclinic.org/neuropodcast and selecting this episode.

Andre Machado, MD, PhD and Imad Najm, MD, discuss a first-of-kind study aimed at identifying biomarkers and targets for preventing and curing neurodegenerative disorders and other neurologic diseases. Receive CME credit for listening to this podcast by visiting clevelandclinic.org/neuropodcast and selecting this episode.

Jessica Vensel Rundo, MD, MS, discusses the screening criteria, ideal candidates and patient outcomes for hypoglossal nerve stimulation in the treatment of obstructive sleep apnea. Receive CME credit for listening to this podcast by visiting clevelandclinic.org/neuropodcast and selecting this episode.

Megan Jack, MD, PhD, discusses the value of peripheral nerve neurosurgery within the nerve injury treatment landscape. Receive CME credit for listening to this podcast by visiting clevelandclinic.org/neuropodcast and selecting this episode.

Yuebing Li, MD, PhD, discusses the current diagnostic and therapeutic guidelines for managing myasthenia gravis. Receive CME credit for listening to this podcast: clevelandclinic.org/neuropodcast.

Dennis Lal, PhD, MS, discusses advances in gene discovery and the prospect of targeted gene therapy for neurologic disorders in both pediatric and adult patients.

Mark Bain, MD and Joao Gomes, MD discuss the state of intracranial hemorrhage diagnosis and treatment, and the advances needed to improve patient prognosis.

Aaron Abrams, MD discusses the efforts that have led to, and continue to evolve, the understanding that earlier, higher efficacy treatments improve outcomes for patients with pediatric-onset demyelinating diseases.

Eighty-five percent of youths ages 12-17 do not receive adequate preparation for their transition from pediatric to adult care. In this episode we address the steps and tools needed to successfully transition care for pediatric patients with neurological disorders.

Multifaceted use of extracranial brain stimulation including, prognostication and prediction of functional recovery, promotion of motor recovery, and surgical mapping are explored with researcher Ela Plow, PhD, in this episode of Neuro Pathways.

Paul Marasco, PhD, discusses the evolving use of bionic technologies to create simultaneous degrees of freedom for individuals with prostheses.

Extensive collaboration on other skull-base tumors has evolved the surgical approach to orbital tumors for Drs. Pablo Recinos and Raj Sindwani. In this episode they discuss multi-handed, endonasal approaches in the narrow corridors of the orbit.

Although neurosarcoidosis is diagnosed in approximately 5% of patients with sarcoidosis, postmortem studies reveal that 10% of sarcoid cases have neurological manifestations. In this episode of Neuro Pathways Brandon Moss, MD, discusses the complexities in diagnosing and treating neurosarcoidosis.

Neurofibromatosis type 2 (NF2) is a rare genetic disorder that is characterized by certain types of tumors that form within the body and the brain. In this episode, Neha Patel, MD discusses the current landscape for managing NF2 patients, including challenges and what's on the horizon for positive patient outcomes.

Brain tumors have proven challenging to treat, largely due to the biological characteristics of the tumors, which often limit treatment progression. In the episode, Justin Lathia, PhD shares insights around the development of new treatment approaches for brain tumor and current research findings that give hope for enhanced survival.

Autoimmune encephalitis and other autoimmune neurologic disorders are increasingly identified causes of unexplained dementia and other neurologic symptoms. In this episode, Amy Kunchok, MD shares insights around the rapidly advancing subspecialty of autoimmune neurology and research in the field.

Individuals who experience trauma at a young age have been shown to have a higher risk of developing alcoholism, depression and suicidality. In this episode, Tatiana Falcone, MD discusses long-term physical and behavioral health concerns, current treatment options and ways physicians can address neurological changes in patients who have experienced adverse childhood trauma.

Child and adolescent health care providers are increasingly caring for patients who identify as lesbian, gay, bisexual, transgender, queer, or other (LGBTQ+), or who may be struggling with or questioning their sexual orientation or gender identity. In this episode, Jason Lambrese, MD discusses behavioral health concerns, clinical management and barriers providers may face in the care of LGBTQ+ adolescents in today's practice.